KyungDong Pharm home
Over-the-Counter Medicines

Gnal-N Deep24 Plaster

Product Category
Analgesic, soothing, astringent, anti-inflammatory
Active Ingredients
Diclofenac Sodium
Appearance
A patch in which a colorless, transparent to light yellow adhesive material is applied to a support and a solid coating is applied to the solid surface.
View Regulatory Information on the MFDS Portal ↗
1. Composition and Strength
[That Day N Deep 24 Plasta Hot]
1 out of 1
- Active ingredient: Diclofenac sodium (BP)----15mg
- Additives: Rubber adhesive solution, vanyl butyl ether, non-woven fabric, sorbitan oleate, acrylic adhesive solution, ethanol, lipid release paper, L-menthol

[That Day N Deep 24 Plasta Cool]
1 out of 1
- Active ingredient: Diclofenac sodium (BP)----15mg
- Additives: Rubber adhesive solution, non-woven fabric, sorbitan oleate, acrylic adhesive solution, ethanol, lipid release paper, L-menthol

2. Effectiveness
Pain relief and anti-inflammatory for the following diseases and symptoms
1) Degenerative arthritis (osteoarthritis)
2) Inflammation around the shoulder joint
3) Tendon and tenosynovitis
4) Paratendinitis
5) Epicondylitis (tennis elbow, etc.)
6) Muscle pain (muscle, myofascial lumbar pain, etc.)
7) Swelling and pain after trauma (wound)

3. Dosage and dosage
Adults (15 years or older): Apply one sheet to the affected area (disease area) once a day.
However, it should not be used by those under 15 years of age.

4. Precautions for use
1. The following people should not use this medicine.
1) Patients with a history of hypersensitivity to this drug or its ingredients
2) Patients with asthma (asthma attacks caused by non-steroidal anti-inflammatory drugs (anti-inflammatory drugs)) or a history of aspirin or other non-steroidal anti-inflammatory drugs (there is a risk of causing severe asthma attacks).
3) Patients with hypersensitivity to aspirin or other non-steroidal anti-inflammatory drugs (anti-inflammatory drugs)
4) Children under 15 years of age (safety has not been established for children (less experience with use))

2. Do not take (use) the following medicines while using this medicine.
Do not apply topically or take diclofenac preparations or non-steroidal anti-inflammatory drugs (anti-inflammatory drugs).

3. The following people should consult a doctor or pharmacist before using this medicine.
1) Patients with bronchial asthma (patients with bronchial asthma include those with aspirin asthma, and there is a risk of causing severe asthma attacks in these patients.)
2) When used for inflammation accompanied by infection (there is a risk that symptoms of skin infection may not appear, so use an appropriate antibacterial or antifungal agent in combination (take together) and use with caution after sufficient observation).
3) When using for chronic diseases (degenerative arthritis (osteoarthritis), etc.) (consider treatments other than drug therapy, sufficiently observe the patient's condition and pay attention to the occurrence (revelation) of adverse reactions.)
4) Pregnant women
(1) Third trimester of pregnancy: Inhibition of prostaglandin synthesis may delay childbirth, and may cause blood loss during birth, neonatal hemorrhage, fetal cardiopulmonary toxicity (pulmonary hypertension accompanying premature closure of the ductus arteriosus), and renal failure accompanied by oligohydramnios due to decreased renal function. Pregnant women at this stage should not use this product.
(2) 1st and 2nd trimester of pregnancy: As a result of animal reproduction experiments, no fetal toxicity occurred, but no studies on pregnant women have yet been revealed.
(3) Nonsteroidal anti-inflammatory drugs (NSAIDs) can interfere with or delay follicular rupture due to their prostaglandin-mediated action mechanism, which can cause reversible infertility in some women. Therefore, women who have difficulty conceiving or are undergoing infertility testing should consider discontinuing the use of NSAIDs, including this drug.
5) Nursing mothers
Although it has not yet been determined whether there is any harm to infants (breastfeeding), this medicine passes into breast milk, so breastfeeding women should not use it.
6) Senior citizens (elderly)
Elderly patients have a higher risk of serious cardiovascular, gastrointestinal, and/or renal adverse events related to NSAIDs than younger patients. In elderly patients, administer with caution at the minimum necessary dose and pay particular attention to the occurrence of adverse reactions.

4. In the following cases, immediately stop using this medicine and consult a doctor or pharmacist. Please carry this attached document with you whenever possible during the consultation.
1) Skin: This drug may cause serious skin adverse reactions such as exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis, which may be fatal. These serious adverse reactions can occur without warning symptoms. In most cases, these adverse reactions occur within the first month of administration. Patients should be aware of significant skin manifestations and symptoms. Sensitivity to light, edema (swelling), skin detachment, eczema, dry skin, sometimes dermatitis, itchiness, reddening due to redness, roughness, irritation, rarely blistering, pigmentation, etc. Contact dermatitis is a particularly serious adverse reaction. Skin symptoms such as redness, red spots, rash, itchiness, and pain appear due to congestion in the area where this drug was used. It may worsen to the back, and may further spread throughout the body and worsen, so if any abnormality is confirmed, stop using it immediately and take appropriate measures.
2) Others: Very rare hypersensitivity reactions, angioneurotic edema (swelling), asthma, etc.

5. Other precautions when using this medicine
1) Please note that treatment with anti-inflammatory painkillers is symptomatic treatment (treatment according to symptoms), not causative treatment.
2) This medication must be reexamined after two weeks of use.
3) Do not use on eyes and mucous membranes.
4) Do not use on areas with damaged skin, eczema, or rashes.
5) Do not use as a sealed bandage method.
6) Be careful when using if your skin is damaged as it may cause temporary irritation and numbness.
7) There is a risk of causing convulsions when used in combination with new quinolone antibacterial agents (enoxacin, etc.), so if convulsions occur, secure the airway and take measures such as intravenous injection of diazepam (animal experiments have reported that new quinolone antibacterial agents inhibit the receptor binding of GABA, an inhibitory neurotransmitter in the brain, in a concentration-dependent manner, and that the inhibitory action is enhanced when coexisting with some non-steroidal anti-inflammatory drugs).
8) If it is not used correctly or if excessive amounts are suddenly used, systemic adverse reactions such as low blood pressure, renal failure, convulsions, gastrointestinal discomfort, and respiratory function depression may occur. In these cases, the general detox method of non-steroidal anti-inflammatory drugs (anti-inflammatory drugs) is used. This treatment method is a symptomatic adjuvant treatment (an auxiliary method of treating symptoms).
9) Clinical trials and post-marketing studies of this drug have confirmed that non-steroidal anti-inflammatory drugs (NSAIDs) in the kidney may reduce the natriuretic effect of loop diuretics (e.g. furosemide) and thiazide diuretics in some patients. During concurrent administration of these drugs and NSAIDs, the diuretic effect, including antihypertensive effect, should be checked, and signs of worsening renal function should be closely observed.
10) NSAIDs, including this drug, may increase the risk of serious gastrointestinal adverse reactions, including stomach or intestinal bleeding, ulcers, and perforation, which may be fatal. For gastrointestinal bleeding, warfarin and NSAIDs may have a synergistic effect. Patients who use the two drugs together may have a higher risk of bleeding compared to when administered alone, so sufficient observation, including blood coagulation ability tests, is required when coadministered with a coumarin-based anticoagulant.
Patients receiving this drug concurrently with drugs that interfere with hemostasis (e.g., warfarin), antiplatelet agents (e.g., aspirin), selective serotonin reuptake inhibitors (SSRIs), and serotonin-norepinephrine reuptake inhibitors (SNRIs) should be observed for signs of bleeding. These adverse reactions may occur without warning symptoms. Additionally, older adults may be at greater risk for serious gastrointestinal adverse events.

6. Storage precautions
1) Keep out of reach of children.
2) Avoid direct sunlight and store in a cool place with as little moisture as possible.
3) Taking medicine out of its original container and storing it in another container may cause an accident due to misuse of the medicine or a decrease in the quality of the medicine, so put it in the original container and keep it tightly closed.

5. How to save
Store in a light-proof, airtight container at room temperature (1~30℃)

6. Packaging unit
10 sheets/package

7. Period of use
36 months from date of manufacture

Product Updates

Total 2items

No.Product NameDetailsDate of ChangeDownload
2Gnal-N Deep24 PlasterPrecautions for use2024.12.12PDF0029_201800891_That Day N Deep 24 Plaster_Precautions for use (draft change).pdf
1Gnal-N Deep24 PlasterPrecautions for use2024.12.12PDFThat Day Deep 24 Plasta_Precautions for use.pdf